On August 1, 2025 Orano reported solid results for first half of 2025.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(Press release, Orano, AUG 1, 2025, View Source;_gl=1*uhwlxo*_gcl_au*MTgwMTY1MTQxMi4xNzY3ODczOTk2 [SID1234661834])